RxDoctor Payments DataLook up a doctor →

Susan Izzo

Family · Vernon, CTNPI 1881644631

Payments from drug & device makers

$17,365in general payments, 2019–2025

Across 1,049 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$2K
  • AstraZeneca$1K
  • GSK$871
  • Lilly USA, LLC$830
  • Amgen$819
  • plus $8K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie227$3,061
Novo Nordisk120$1,791
AstraZeneca75$1,408
GSK57$871
Lilly USA, LLC42$830
Amgen58$819
Pfizer52$730
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)27$525
Lundbeck LLC30$481
Johnson & Johnson26$466
Astellas Pharma US Inc21$442
Otsuka America Pharmaceutical, Inc.22$438
Boehringer Ingelheim19$405
Sanofi-aventis U.S. LLC19$351
Vanda Pharmaceuticals Inc.17$343
Phathom Pharmaceuticals, Inc.24$309
Dexcom, Inc.14$283
Exact Sciences14$262
Idorsia Pharmaceuticals US Inc14$235
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$215
E.r. Squibb & Sons, L.L.C.9$197
Abbott11$194
Bayer8$156
Sunovion Pharmaceuticals Inc.9$145
Merck8$138
Takeda Pharmaceuticals U.S.A., Inc.7$134
Kowa Pharmaceuticals America, Inc.9$132
Corcept Therapeutics5$127
Biohaven Pharmaceutical Holding Company Ltd.7$125
Eisai Inc.7$121
Shield Therapeutics Inc6$114
Teva Pharmaceuticals USA, Inc.5$112
Sumitomo Pharma America, Inc.5$106
Novartis4$95
Ardelyx, Inc.4$82
Almatica Pharma LLC4$76
Amarin Pharma, Inc.5$70
Resmed Corp1$66
Amneal Pharmaceuticals LLC3$55
Bausch Health US, LLC3$54
Boston Scientific2$50
Actelion Pharmaceuticals US, Inc.2$50
Insightec,inc2$50
Scilex Pharmaceuticals Inc.2$49
Radius Health, Inc.3$48
Evoke Pharma, Inc.3$45
QOL Medical, LLC2$44
Soleno Therapeutics, Inc.2$44
Cequr Corporation1$42
Axsome Therapeutics, Inc.2$40
Valinor Pharma, LLC2$39
Biohaven Pharmaceuticals, Inc.2$37
Collegium Pharmaceutical, Inc.2$30
Neurocrine Biosciences, Inc.1$26
Seqirus USA Inc1$23
Corium, LLC1$21
Xeris Pharmaceuticals, Inc.1$20
Antares Pharma, Inc.1$19
Otsuka Pharmaceutical Development & Commercialization, Inc.1$19
Inspire Medical Systems, Inc.1$16

How this compares

$17,365 in reported general payments places this provider in the 95th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut →

Medicare billing

Part B allowed, 2024
$44,104
Medicare patients
121
Services billed
703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Vernon

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →